{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T21:14:26Z","timestamp":1771708466898,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation","doi-asserted-by":"publisher","award":["81973136"],"award-info":[{"award-number":["81973136"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.ygyno.2020.01.011","type":"journal-article","created":{"date-parts":[[2020,1,18]],"date-time":"2020-01-18T07:41:58Z","timestamp":1579333318000},"page":"202-208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Clinical performance of Onclarity HPV assay and Cobas HPV test in detection of cervical precancer and cancer in Chinese women"],"prefix":"10.1016","volume":"157","author":[{"given":"Tingyuan","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeni","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingyue","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2736-4766","authenticated-orcid":false,"given":"Yuqian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lulu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianfeng","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinjing","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daokuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youlin","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 10","key":"10.1016\/j.ygyno.2020.01.011_bb0005","doi-asserted-by":"crossref","first-page":"K29","DOI":"10.1016\/j.vaccine.2008.06.019","article-title":"Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries","volume":"26","author":"Cuzick","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.ygyno.2020.01.011_bb0010","first-page":"115","article-title":"Cancer statistics in China, 2015","volume":"66","author":"Chen","year":"2016","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2020.01.011_bb0015","first-page":"19","article-title":"Report of cancer epidemiology in China, 2015","volume":"41","author":"Zheng","year":"2019","journal-title":"Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]"},{"key":"10.1016\/j.ygyno.2020.01.011_bb0020","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.canep.2018.12.013","article-title":"Evaluation of p16\/Ki-67 dual staining in the detection of cervical precancer and cancer in China","volume":"59","author":"Zhang","year":"2019","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.ygyno.2020.01.011_bb0025","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/1471-0528.14783","article-title":"Accuracy of combinations of visual inspection using acetic acid or lugol iodine to detect cervical precancer: a meta-analysis","volume":"125","author":"Catarino","year":"2018","journal-title":"BJOG: An International Journal of Obstetrics and Gynaecology"},{"key":"10.1016\/j.ygyno.2020.01.011_bb0030","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S1470-2045(08)70210-9","article-title":"A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China","volume":"9","author":"Qiao","year":"2008","journal-title":"The Lancet Oncology"},{"key":"10.1016\/j.ygyno.2020.01.011_bb0035","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J. Pathol."},{"key":"10.1016\/j.ygyno.2020.01.011_bb0040","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1517\/14656566.2011.596527","article-title":"Human papillomavirus: science and technologies for the elimination of cervical cancer","volume":"12","author":"Bosch","year":"2011","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.ygyno.2020.01.011_bb0045","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ygyno.2014.11.076","article-title":"Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test","volume":"136","author":"Wright","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2020.01.011_bb0050","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S1470-2045(11)70188-7","article-title":"Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25\u00a0years and older: a subanalysis of the ATHENA study","volume":"12","author":"Castle","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2020.01.011_bb0055","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/bjc.2013.22","article-title":"Comparing the performance of six human papillomavirus tests in a screening population","volume":"108","author":"Cuzick","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2020.01.011_bb0060","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.cmi.2015.04.015","article-title":"Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?","volume":"21","author":"Arbyn","year":"2015","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ygyno.2020.01.011_bb0065","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1128\/JCM.01366-15","article-title":"Clinical and analytical performance of the Onclarity HPV assay using the VALGENT framework","volume":"53","author":"Cuschieri","year":"2015","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ygyno.2020.01.011_bb0070","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1128\/JCM.00246-15","article-title":"Comparison of Onclarity human papillomavirus (HPV) assay with hybrid capture II HPV DNA assay for detection of cervical intraepithelial neoplasia grade 2 and 3 lesions","volume":"53","author":"Bottari","year":"2015","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ygyno.2020.01.011_bb0075","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01910-17","article-title":"Validation of a human papillomavirus (HPV) DNA cervical screening test that provides expanded HPV typing","volume":"56","author":"Demarco","year":"2018","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ygyno.2020.01.011_bb0080","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1128\/JCM.00181-12","article-title":"Comparison of seven tests for high-grade cervical intraepithelial neoplasia in women with abnormal smears: the predictors 2 study","volume":"50","author":"Szarewski","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ygyno.2020.01.011_bb0085","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/ajcp\/aqy124","article-title":"Comparison study of BD Onclarity HPV with digene HC2 high-risk HPV DNA test and roche cobas 4800 HPV for detecting high-risk human papillomavirus in Japan","volume":"151","author":"Nakamura","year":"2019","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.ygyno.2020.01.011_bb0090","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jmoldx.2011.09.005","article-title":"Analytical comparison of the cobas HPV test with hybrid capture 2 for the detection of high-risk HPV genotypes","volume":"14","author":"Lindemann","year":"2012","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.ygyno.2020.01.011_bb0095","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1309\/AJCP53KMHNRDICBL","article-title":"Clinical performance of the BD Onclarity HPV assay using an adjudicated cohort of BD SurePath liquid-based cytology specimens","volume":"142","author":"Wright","year":"2014","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.ygyno.2020.01.011_bb0100","first-page":"95","article-title":"Human papillomavirus (HPV) 16\/18 E6 oncoprotein expression in infections with single and multiple genotypes","volume":"12","author":"Wu","year":"2019"},{"key":"10.1016\/j.ygyno.2020.01.011_bb0105","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1002\/ijc.30012","article-title":"Risk assessment to guide cervical screening strategies in a large Chinese population","volume":"138","author":"Zhao","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2020.01.011_bb0110","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1128\/JCM.00759-13","article-title":"Long-term stability of human genomic and human papillomavirus DNA stored in BD SurePath and Hologic PreservCyt liquid-based cytology media","volume":"51","author":"Agreda","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ygyno.2020.01.011_bb0115","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1128\/JCM.02025-16","article-title":"Stability study of cervical specimens collected by swab and stored dry followed by human papillomavirus DNA detection using the cobas 4800 test","volume":"55","author":"Lin","year":"2017","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ygyno.2020.01.011_bb0120","first-page":"921","article-title":"Association between high-risk human papillomavirus DNA load and cervical intraepithelial lesion","volume":"25","author":"Zhao","year":"2004","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi"},{"key":"10.1016\/j.ygyno.2020.01.011_bb0125","first-page":"475","article-title":"Association between high risk human papillomavirus DNA load and cervical lesions in different infection status","volume":"40","author":"Li","year":"2018","journal-title":"Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]"},{"key":"10.1016\/j.ygyno.2020.01.011_bb0130","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.pvr.2016.01.003","article-title":"Clinical and analytical performance of the BD Onclarity HPV assay for detection of CIN2+ lesions on SurePath samples","volume":"2","author":"Ejegod","year":"2016","journal-title":"Papillomavirus Research"},{"key":"10.1016\/j.ygyno.2020.01.011_bb0135","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/ajcp\/aqy084","article-title":"Detection of cervical neoplasia by human papillomavirus testing in an atypical squamous cells-undetermined significance population: results of the Becton Dickinson Onclarity Trial","volume":"151","author":"Wright","year":"2019","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.ygyno.2020.01.011_bb0140","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1309\/AJCPZ5JY6FCVNMOT","article-title":"High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study","volume":"135","author":"Stoler","year":"2011","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.ygyno.2020.01.011_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119755","article-title":"Primary screening for cervical cancer based on high-risk human papillomavirus (HPV) detection and HPV 16 and HPV 18 genotyping, in comparison to cytology","volume":"10","author":"Agorastos","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2020.01.011_bb0150","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S1470-2045(11)70188-7","article-title":"Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25\u00a0years and older: a subanalysis of the ATHENA study","volume":"12","author":"Castle","year":"2011","journal-title":"The Lancet Oncology"},{"key":"10.1016\/j.ygyno.2020.01.011_bb0155","doi-asserted-by":"crossref","first-page":"8813","DOI":"10.1158\/0008-5472.CAN-08-1380","article-title":"Prevalence, acquisition, and clearance of cervical human papillomavirus infection among women with normal cytology: Hawaii Human Papillomavirus Cohort Study","volume":"68","author":"Goodman","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2020.01.011_bb0160","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/cncy.20177","article-title":"Comparison of ThinPrep and SurePath liquid-based cytology and subsequent human papillomavirus DNA testing in China","volume":"119","author":"Zhao","year":"2011","journal-title":"Cancer Cytopathology"},{"key":"10.1016\/j.ygyno.2020.01.011_bb0165","first-page":"411","article-title":"Prevalence of cervical intraepithelial neoplasia in patients with atypical squamous cells of undetermined significance from cervical pap smears in Beijing","volume":"32","author":"Wang","year":"2011","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"10.1016\/j.ygyno.2020.01.011_bb0170","doi-asserted-by":"crossref","first-page":"62411","DOI":"10.18632\/oncotarget.11498","article-title":"Prevalence of human papillomavirus infection and genotyping for population-based cervical screening in developed regions in China","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ygyno.2020.01.011_bb0175","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1089\/jwh.2009.1866","article-title":"Risk factors for cervical abnormalities among Hong Kong Chinese women: a large-scale community-based cervical screening program","volume":"20","author":"Wong","year":"2011","journal-title":"Journal of Women\u2019s Health (2002)"},{"key":"10.1016\/j.ygyno.2020.01.011_bb0180","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1158\/1055-9965.EPI-10-0212","article-title":"A population-based study on the risks of cervical lesion and human papillomavirus infection among women in Beijing, People\u2019s Republic of China","volume":"19","author":"Li","year":"2010","journal-title":"Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology"},{"key":"10.1016\/j.ygyno.2020.01.011_bb0185","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/LGT.0000000000000103","article-title":"Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance","volume":"19","author":"Huh","year":"2015","journal-title":"Journal of Lower Genital Tract Disease"},{"key":"10.1016\/j.ygyno.2020.01.011_bb0190","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jinf.2018.02.008","article-title":"Prevalence and distribution of human papillomavirus genotypes in Chinese women between 1991 and 2016: a systematic review","volume":"76","author":"Zhou","year":"2018","journal-title":"The Journal of Infection"},{"key":"10.1016\/j.ygyno.2020.01.011_bb0195","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ygyno.2018.12.024","article-title":"Stratified risk of high-grade cervical disease using onclarity HPV extended genotyping in women, >\/=25\u00a0years of age, with NILM cytology","volume":"153","author":"Stoler","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2020.01.011_bb0200","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ygyno.2019.05.012","article-title":"Risk detection for high-grade cervical disease using Onclarity HPV extended genotyping in women, >\/=21\u00a0years of age, with ASC-US or LSIL cytology","volume":"154","author":"Wright","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2020.01.011_bb0205","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1128\/JCM.02116-14","article-title":"A study of genotyping for management of human papillomavirus-positive, cytology-negative cervical screening results","volume":"53","author":"Schiffman","year":"2015","journal-title":"J. Clin. Microbiol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825820300226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825820300226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:48:53Z","timestamp":1758772133000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825820300226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0090825820300226"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2020.01.011","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical performance of Onclarity HPV assay and Cobas HPV test in detection of cervical precancer and cancer in Chinese women","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2020.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}